Home › Triple-Negative Breast Cancer › Connecticut › New Haven

Pag-aaral pangklinika para sa Triple-Negative Breast Cancer sa New Haven, CT

Isang pag-aaral para sa Triple-Negative Breast Cancer ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa New Haven. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Nagre-recruitPhase 1/2

Yale Cancer Center, New Haven

Edad 12 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04585750

Study of AVZO-021 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Avenzo Therapeutics Recruiting Site, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT05867251

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Nagre-recruitPhase 3

Yale Cancer Center ( Site 0053), New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT06393374

Lifestyle, Exercise, And Nutrition (LEAN) Trial on Pathologic Complete Response in TNBC

Nagre-recruit

Yale University, New Haven

Edad 18 pataas · Kababaihan · Na-update Set 25, 2026 · NCT07066189

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Nagre-recruitPhase 1

Yale University, Yale Cancer Center, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

Nagre-recruitPhase 2

Yale Cancer Center Clinical Trials Office, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT07340541

First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

Nagre-recruitPhase 1/2

Yale Cancer Center, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Set 11, 2026 · NCT06657222

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

Nagre-recruitPhase 1

Yale Cancer Center, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 28, 2026 · NCT07029399

A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Nagre-recruitPhase 1

Normunity Investigational Site, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 18, 2026 · NCT07182149

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

Nagre-recruitPhase 1

Yale New Haven Hospital, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT05768932

Saci Nivo Rela for TNBC

Nagre-recruitPhase 1/2Malugod na tinatanggap ang malusog na boluntaryo

Yale University, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update May 22, 2026 · NCT06963905

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

Nagre-recruitPhase 2

Yale Cancer Center, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update May 6, 2026 · NCT01042379

Food for Thought - A Nutrition Intervention for Women Undergoing Active Treatment for Triple Negative Breast Cancer

Nagre-recruit

Yale University, New Haven

Edad 40 hanggang 65 · Kababaihan · Na-update Dis 11, 2025 · NCT06582615

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

Nagre-recruitPhase 1/2

Yale Cancer Center, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2025 · NCT05902988

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Nagre-recruitPhase 1/2

Yale Cancer Center, New Haven

Edad 18 pataas · Lahat ng kasarian · Na-update Nob 15, 2024 · NCT04787042

Pag-aaral para sa Triple-Negative Breast Cancer sa ibang lungsod

Iba pang pag-aaral sa New Haven

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.